Nanobiotix Investor Relations Material
Latest events
Status Update
Nanobiotix
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Nanobiotix S.A.
Access all reports
Nanobiotix S.A. is a biotechnology company that focuses on developing nanomedicine products for cancer treatment. The company's proprietary technology, NanoXray, involves nanoparticles that enhance the effects of radiotherapy by increasing the absorption of X-rays within cancer cells. This approach is designed to improve the precision and effectiveness of radiotherapy, potentially reducing side effects and improving patient outcomes. Nanobiotix's products are primarily in the clinical stages of development, and the company continues to advance its pipeline for various cancer types. The company is headquartered in Paris, France, and its shares are listed on the Euronext Paris.
Key slides for Nanobiotix S.A.
Q4 2024
Nanobiotix S.A.
Study Update
Nanobiotix S.A.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
NANO
Country
🇫🇷 France